(cytomegalovirus HIV) AND (randomized controlled trial[Publication Type] OR (randomized[Title/Abstract] AND controlled[Title/Abstract] AND trial[Title/Abstract]))

Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.

Casper C, Krantz EM, Corey L, Kuntz SR, Wang J, Selke S, Hamilton S, Huang ML, Wald A.

J Infect Dis. 2008 Jul 1;198(1):23-30.

PMID: 18491970 [PubMed - indexed for MEDLINE]

Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.

Plana M, Ferrer E, Martínez C, Podzamczer D, García F, Maleno MJ, Barceló JJ, García A, Barberá MJ, Lacarcel M, Miró JM, Gallart T, Gatell JM.

Antivir Ther. 2004 Apr;9(2):197-204.

PMID: 15134181 [PubMed - indexed for MEDLINE]

[Heparin Surface-Modified Poly(methylmethacrylate) and Foldable Hydrophobic Acrylic Intraocular Lenses in Cataract Patients with Acquired Immune Deficiency Syndrome and CMV-Retinitis]

Krieglsteiner S, Gümbel HO, Kohnen T.

Klin Monatsbl Augenheilkd. 2004 Jan;221(1):40-6. German.

PMID: 14745677 [PubMed - indexed for MEDLINE]

Cytomegalovirus-specific IFN-gamma production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy.

Weinberg A, Wohl DA, MaWhinney S, Barrett RJ, Brown DG, Glomb N, van der Horst C.

AIDS. 2003 Nov 21;17(17):2445-50.

PMID: 14600515 [PubMed - indexed for MEDLINE]

Absence of activation of CMV by blood transfusion to HIV-infected, CMV-seropositive patients.

Drew WL, Chou S, Mohr BA, Assmann SF, Miner RC, Laycock ME, Busch MP; Viral Activation Transfusion Study Group.

Transfusion. 2003 Oct;43(10):1351-7.

PMID: 14507264 [PubMed - indexed for MEDLINE]

Jacobson DL, Wu AW, Feinberg J; Outcomes Committee of the Adult AIDS Clinical Trials Group.

J Clin Epidemiol. 2003 Sep;56(9):874-9.

PMID: 14505773 [PubMed - indexed for MEDLINE]

Phase I safety and pharmacokinetic trials of 1263W94, a novel oral anti-human cytomegalovirus agent, in healthy and human immunodeficiency virus-infected subjects.

Wang LH, Peck RW, Yin Y, Allanson J, Wiggs R, Wire MB.

Antimicrob Agents Chemother. 2003 Apr;47(4):1334-42.

PMID: 12654667 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

11:

Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.

Nokta MA, Holland F, De Gruttola V, Emery VC, Jacobson MA, Griffiths P, Pollard RB, Feinberg JE; AIDS Clinical Trials Group, Protocol 204/GlaxoWellcome 123-014, International CMV Prophylaxis Study Group.

J Infect Dis. 2002 Jun 15;185(12):1717-22. Epub 2002 May 31.

PMID: 12085316 [PubMed - indexed for MEDLINE]

12:

Immunologic reconstitution after 1 year of highly active antiretroviral therapy, with or without protease inhibitors.

Plana M, Martínez C, García F, Maleno MJ, Barceló JJ, García A, Lejeune M, Vidal C, Cruceta A, Miró JM, Pumarola T, Gallart T, Gatell JM.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):429-34.

PMID: 11981357 [PubMed - indexed for MEDLINE]

13:

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

Martin DF, Sierra-Madero J, Walmsley S, Wolitz RA, Macey K, Georgiou P, Robinson CA, Stempien MJ; Valganciclovir Study Group.

N Engl J Med. 2002 Apr 11;346(15):1119-26. Erratum in: N Engl J Med 2002 Sep 12;347(11):862.

PMID: 11948271 [PubMed - indexed for MEDLINE]

14:

HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.

Jabs DA, Gilpin AM, Min YI, Erice A, Kempen JH, Quinn TC; Studies of Ocular Complications of AIDS Research Group.

AIDS. 2002 Apr 12;16(6):877-87.

PMID: 11919489 [PubMed - indexed for MEDLINE]

15:

Signs and symptoms associated with the transfusion of WBC-reduced RBCs and non-WBC-reduced RBCs in patients with anemia and HIV infection: results from the Viral Activation Transfusion Study.

Lane TA, Gernsheimer T, Mohandas K, Assmann SF.

Transfusion. 2002 Feb;42(2):265-74.

PMID: 11896345 [PubMed - indexed for MEDLINE]

16:

Assessing the utility of five domains in SF-12 Health Status Questionnaire in an AIDS clinical trial.

Han C, Pulling CC, Telke SE, Huppler Hullsiek K; Terry Beirn Community Programs for Clinical Research on AIDS.

AIDS. 2002 Feb 15;16(3):431-9.

PMID: 11834955 [PubMed - indexed for MEDLINE]

17:

The safety and efficacy of adefovir dipivoxil in patients with advanced HIV disease: a randomized, placebo-controlled trial.

Fisher EJ, Chaloner K, Cohn DL, Grant LB, Alston B, Brosgart CL, Schmetter B, El-Sadr WM, Sampson J; Terry Beirn Community Programs for Clinical Research on AIDS.

AIDS. 2001 Sep 7;15(13):1695-700.

PMID: 11546945 [PubMed - indexed for MEDLINE]

18:

Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.

Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ; Viral Activation Transfusion Study Investigators.

Ann Intern Med. 2001 Jul 3;135(1):17-26.

PMID: 11434728 [PubMed - indexed for MEDLINE]

19:

A phase III study of recombinant human interferon gamma to prevent opportunistic infections in advanced HIV disease.

Riddell LA, Pinching AJ, Hill S, Ng TT, Arbe E, Lapham GP, Ash S, Hillman R, Tchamouroff S, Denning DW, Parkin JM.

AIDS Res Hum Retroviruses. 2001 Jun 10;17(9):789-97.

PMID: 11429120 [PubMed - indexed for MEDLINE]

20:

Acyclovir: no survival benefit seen in a large study.

[No authors listed]

TreatmentUpdate. 1998 Mar;10(1):3-5.

PMID: 11365431 [PubMed - indexed for MEDLINE]

Recent Activity